Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy

Abstract Introduction A systematic literature review and network meta-analysis (NMA) were conducted to compare the short-term efficacy of lebrikizumab to other biologic and Janus kinase (JAK) inhibitor monotherapies approved for moderate-to-severe atopic dermatitis in adults and adolescents. Methods...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, Lisa Beck, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Alan D. Irvine, Peter Foley, James Del Rosso, Linda Stein Gold, Erin Johansson, Martin Dossenbach, Gaia Gallo, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Tristan Curteis, Raj Chovatiya
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Adis, Springer Healthcare 2025-02-01
Sarja:	Dermatology and Therapy
Aiheet:	Atopic dermatitis Eczema Area and Severity Index Investigator Global Assessment Lebrikizumab Network meta-analysis Pruritus/itch Numeric Rating Scale
Linkit:	https://doi.org/10.1007/s13555-025-01357-7
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!